{"filing":{"accession_number":"0001062993-26-003060","cik":"0001997296","ticker":"MDCXW","company_name":"Medicus Pharma Ltd.","form":"8-K","filing_date":"2026-06-04","report_date":null,"primary_document":"form8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1997296/000106299326003060/form8k.htm"},"events":[{"id":6727,"run_id":5891,"accession_number":"0001062993-26-003060","anchor_item_number":"5.07","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"summary":"This Item 5.07 discloses the results of Medicus Pharma's 2026 Annual General and Special Meeting of Shareholders held on June 3, 2026, including voting outcomes on three proposals: ratification of KPMG LLP as auditor, election of nine directors, and approval of a special resolution authorizing share consolidation up to a 50:1 ratio. The disclosure is a direct and complete reporting of shareholder voting results as required by Item 5.07.","company_name":"Medicus Pharma Ltd.","ticker":"MDCXW","filing_date":"2026-06-04","form":"8-K","submitted_at":null,"items":[{"id":4236,"accession_number":"0001062993-26-003060","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This Item 5.07 discloses the results of Medicus Pharma's 2026 Annual General and Special Meeting of Shareholders held on June 3, 2026, including voting outcomes on three proposals: ratification of KPMG LLP as auditor, election of nine directors, and approval of a special resolution authorizing share consolidation up to a 50:1 ratio. The disclosure is a direct and complete reporting of shareholder voting results as required by Item 5.07.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-05T04:51:22.602627+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":4236,"accession_number":"0001062993-26-003060","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This Item 5.07 discloses the results of Medicus Pharma's 2026 Annual General and Special Meeting of Shareholders held on June 3, 2026, including voting outcomes on three proposals: ratification of KPMG LLP as auditor, election of nine directors, and approval of a special resolution authorizing share consolidation up to a 50:1 ratio. The disclosure is a direct and complete reporting of shareholder voting results as required by Item 5.07.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-05T04:51:22.602627+00:00","company_name":"Medicus Pharma Ltd.","ticker":"MDCXW","filing_date":"2026-06-04"}]}